Trump To Legalize Hemp... This Niche Industry Is Set to Surge

Trouble viewing this e-mail? [Click here to read it online]( [CASEY DAILY DISPATCH - Casey Research] Justin’s note: Today, we have a special morning edition of the Dispatch for you... because Crisis Investing chief analyst Nick Giambruno has urgent news to share regarding the marijuana industry. In short, President Trump is going to sign an important bill that will make a niche industry within the marijuana sector soar. Read on to see why this is so important for your portfolio, and what you can do now to start profiting… --------------------------------------------------------------- Trump To Legalize Hemp… This Niche Industry Is Set to Surge By Nick Giambruno, chief analyst, Crisis Investing President Trump is opening the floodgates… That’s because he’s going to sign the 2018 Farm Bill into law. Within that bill is a provision to legalize industrial hemp at the federal level for the first time in over 70 years. Previously, the Controlled Substances Act made certain parts of any cannabis plant – regardless of its THC content – an illegal Schedule I substance. That includes hemp. However, certain components of the cannabis plant, like the mature stalks, weren’t considered illegal. But you couldn’t grow the legal parts without also growing the illegal parts. That previously made growing hemp in the U.S. illegal and forced stores selling hemp products to be reliant on imports – mainly from China and Canada. However, that’s all going to change… Now that President Trump is legalizing hemp at the federal level, the floodgates have opened for hemp production on a massive industrial scale in the U.S. It’s worth noting that the oracles at Whole Foods say hemp will be a “Top 10” product in 2019. And now that hemp is going to be legal at the federal level, I expect another niche industry in the cannabis market to soar… I’m talking about the CBD (cannabidiol) market. You see, this bill not only legalizes hemp production… but also CBD oil extraction. [As I’ve written in the past]( industrial hemp is used for its rich CBD content. This is a major development. In a minute, I’ll explain why the CBD oil market is set to explode… but first, let me tell you a remarkable story that shows just how powerful CBD is… Recommended Link [Nick’s Going to Drink “Liquid Money” [LIVE Demo]]( It’s a first-ever Casey Research event... On camera, chief analyst Nick Giambruno is going to drink a substance some researchers call “liquid money.” Why the strange name? Analysts project it could grow into half a trillion dollars in value. Fox News calls this drink, “A Miracle in a Bottle.” And Rolling Stone says, “It’s the drug of the future.” You’re going to see it in all the grocery stores soon. Whole Foods declares it’ll be one of the top sellers of 2019. The entire industry is heating up. Soon variations of this product will be in almost every home in America. And some homes will buy LOTS of it every month. So if you thought PCs were big, you haven’t seen anything yet! Billionaire investors like Leon Cooperman and Peter Thiel are piling into this space. So is hedge fund and ETF giant Vanguard. And if you want a life-changing payday, you should, too! Nick Giambruno answers your questions in our most exciting briefing to date! [Click here to watch Nick drink “liquid money”]( -- How CBD Gave Charlotte a Second Chance at Life "We've seen her flatline in the hospital and say goodbye… I don’t think she's going to survive this." These are the words of Charlotte Figi’s father, recalling what it was like to see his five-year-old daughter’s heart stop beating. At the time, Charlotte was having over 40 seizures a day. The seizures reduced her to a vegetative state and pushed her near death. A few years earlier, Charlotte had been diagnosed with Dravet syndrome. It’s a rare form of severe epilepsy with no known cure. It lasts a lifetime and often kills young children. Charlotte’s parents had tried everything to help their daughter. They made lifestyle changes. They gave her powerful prescription drugs. But traditional drugs only made the situation worse. At one point, Charlotte could no longer walk or talk. Eventually, she couldn’t even eat. Doctors said the only option was to put her in a medically induced coma. Desperate, her father researched alternative treatments. Eventually, he discovered a video about another family with a young child suffering from seizures. Medical marijuana was the one thing that worked for them. Initially, Charlotte’s parents thought medical marijuana was impractical because of its complicated legal situation. Nevertheless, they decided to pursue it. They’d already exhausted every other option. The first step was relocating to Colorado, one of the first states to legalize medical marijuana. Then, they had to convince two doctors to prescribe it. (The state required two doctors to sign off on marijuana prescriptions for children.) Both doctors were reluctant. But they knew Charlotte was on the brink of death. So they gave it a shot. Prescription in hand, Charlotte’s parents still needed to find a special strain of cannabis – one with low amounts of THC (the compound that gets people high), but a high amount of CBD. CBD has medicinal properties, but no intoxicating effects. Doctors think it can help stabilize chemical and electrical activity in the brain, producing an anticonvulsant effect. Eventually, Charlotte’s parents found growers who could help. After years of crossbreeding a strain of marijuana with industrial hemp, they had developed a strain with less THC and more CBD than typical varieties of marijuana. The next step was extracting the oil from the dried cannabis flowers. Then they could give the cannabis oil to Charlotte. The results were shocking. On the first day of treatment, she didn’t have any seizures. None. Normally, she would have had over 40. Recommended Link [Did This Tiny Company Just Flip Tesla’s Kill Switch?]( Elon Musk believes electric vehicles are the future of transportation, and he wants Tesla to lead the charge. But, thanks to these three digits, all his work could be for nothing. You see, these digits are the codename for this brand-new technology... One that threatens to derail the entire electric vehicle revolution... And spark a 22,705% profit surge for one tiny U.S. company. [Click here for details]( -- Using the cannabis oil, Charlotte went a week without seizures. Without it, she normally would have had over 300. It didn’t take long for Charlotte to start eating again… then feeding herself… then talking and walking. Within a year of starting CBD treatments, Charlotte learned how to ride a bike. Charlotte has continued to take CBD treatments daily. Now, six year later, she lives a mostly normal life. The marijuana growers that grew the high-CBD, low-THC strain of cannabis for Charlotte named it “Charlotte’s Web.” Charlotte’s story has helped pave the way for countless other children and adults suffering from seizures. It was featured on CNN. It’s also helped galvanize national support for cannabis legalization. Promising New CBD Research So far, 33 states have legalized medical marijuana. Ten have also legalized recreational use. But marijuana is still illegal at the federal level. For the time being, the U.S. federal government classifies it as a Schedule I drug. Heroin and LSD are in the same category. Marijuana’s schedule I status means the feds believe it has “no accepted medical use.” That’s about as absurd as saying the Earth is flat. But this has been their official view for decades. This is why it’s been so difficult to study marijuana’s medicinal properties, despite its obvious health benefits. But that’s finally starting to change. According to three clinical studies – two published in The New England Journal of Medicine and one in The Lancet – CBD was found to significantly reduce seizures. And earlier this year, the FDA finally approved its first prescription CBD medicine to treat epilepsy… nearly five years after CNN aired Charlotte’s story. There’s good reason to think CBD has a wider range of medicinal benefits. It’s already been used to help treat conditions like Parkinson's disease, glaucoma, migraines, cancer, and arthritis, among others. CBD is also thought to have therapeutic benefits. It can help with immunosuppression, neuroprotection, and appetite and bone-growth stimulation. Because of its many applications, the market for CBD consumer products and pharmaceuticals is enormous. Market research suggests that the U.S. CBD market is currently worth around $500 million. But it could easily skyrocket to over $10 billion within the next three years. That’s 20 times its current size. As impressive as that sounds, I think it’s probably conservative. Sales of Epidiolex, the CBD drug that the FDA approved, are expected to reach $1.3 billion over a similar time frame. And that’s just one CBD product. I think the U.S. CBD market could easily grow 10 times larger in the years ahead. Shares of select publicly traded companies in the CBD industry could surge even higher. This is presenting investors with another new, huge opportunity to profit from the legal cannabis megatrend. The time to position yourself is now. Regards, Nick Giambruno Chief Analyst, Crisis Investing P.S. Only one CBD oil stock is uniquely positioned to ride the crest of this wealth wave. This is the most lucrative opportunity I have seen in a long time. That’s why watching my new video presentation is imperative. [Click here to view now.]( [FACEBOOK]( [TWITTER]( [GOOGLE +]( [SUBSCRIBE]( © Casey Research, LLC 455 NE 5th Ave, Suite D317 Delray Beach, FL 33483 [www.caseyresearch.com]( The email was sent to {EMAIL} because you are subscribed to this service. To unsubscribe, click [here](. Customer Service Casey Research welcomes your feedback and questions. But please note: The law prohibits us from giving personalized advice. To contact us, call Toll Free: (888) 512-2739, International: (602) 445-2736, Monday–Friday, 9 a.m.–7 p.m. ET, or email us at feedback@caseyresearch.com. Having trouble getting your emails? Add us to your address book. © 2018 Casey Research, 455 NE 5th Ave, Suite D317, Delray Beach, FL 33483, USA. All rights reserved. Any reproduction, copying, or redistribution, in whole or in part, is prohibited without written permission from the publisher. Information contained herein is obtained from sources believed to be reliable, but its accuracy cannot be guaranteed. It is not designed to meet your personal situation—we are not financial advisors nor do we give personalized advice. The opinions expressed herein are those of the publisher and are subject to change without notice. It may become outdated and there is no obligation to update any such information. Recommendations in Casey Research publications should be made only after consulting with your advisor and only after reviewing the prospectus or financial statements of the company in question. You shouldn’t make any decision based solely on what you read here. Casey Research writers and publications do not take compensation in any form for covering those securities or commodities. Casey Research expressly forbids its writers from owning or having an interest in any security that they recommend to their readers. Furthermore, all other employees and agents of Casey Research and its affiliate companies must wait 24 hours before following an initial recommendation published on the Internet, or 72 hours after a printed publication is mailed.